Article PDF
References
Orci L, Baetens D, Rufener C, Amherdt M, Ravazzola M, Studer P, Malaisse-Lagae F, Unger RH (1976) Hypertrophy and hyperplasia of somatostatin-containing D cells in diabetes. Proc Natl Acad Sci USA 73: 1338–1342
Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619–633
Nerup J, Andersen OO, Bendixen G, Egeberg J, Poulsen JE (1973) Anti-pancreatic, cellular hypersensitivity in diabetes mellitus. Antigenic activity of fetal calf pancreas and correlation with clinical type of diabetes. Acta allerg 28: 223–230
Cudworth AG (1980) Current concepts of aetiology: Type 1 (insulin dependent) diabetes mellitus. In: Bellingham AJ (ed) Advanced medicine, vol 16. Pitman Medical, Bath, pp 123–135
Platz P, Jakobsen BK, Morling M, Ryder LP, Svejgaard A, Thomsen M, Christy M, Kromann H, Benn J, Nerup J, Green A, Hauge M (1981) HLA-Dand DR-antigens in genetic analysis of insulin-dependent diabetes mellitus. Diabetologia 21: 108–115
McDevitt HO (1980) Regulation of the immune response by the major histocompatibility system. N Engl J Med 303: 1514–1517
Götze D (ed) (1977) The major histocompatibility system in man and animals. Springer Verlag, Berlin Heidelberg New York, pp 1–7
Bottazzo GF, Pujol-Borrell R, Doniach D (1981) Humoral and cellular immunity in diabetes mellitus. Clin Immunol Allergy 1: 139–159
Irvine WJ (1979) Immunological aspects of diabetes mellitus. In: Pierluissi J (ed) Endocrine Pancreas and Diabetes. Excerpta Medica, Amsterdam, pp 281–299
Lernmark Å, Hägglöf B, Freedman ZR, Irvine WJ, Ludvigsson J, Holmgren G (1981) A prospective analysis of antibodies reactive with pancreatic islet cells in insulin-dependent diabetic children. Diabetologia 20: 471–474
Freedman ZR, Feed CM, Irvine WJ, Lernmark Å, Rubenstein AH, Steiner DF, Huen A (1979) Islet cell cytoplasmic and cell surface antibodies in diabetes mellitus. Trans Assoc Am Physicians 96: 64–76
Lernmark Å, Kanatsuna T, Patzelt C, Diakoumis K, Carroll R, Rubenstein AH, Steiner DF (1980) Antibodies directed against the pancreatic islet cell plasma membrane. Diabetologia 19: 445–451
Eisenbarth GS, Morris MA, Searce RM (1981) Cytotoxic antibodies to cloned rat islet cells in serum of patients with diabetes mellitus. J Clin Invest 67: 403–408
Gazdar AF, Chick WL, Oie HK, Sims HL, King DL, Weir GC, Laurits V (1980) Continuous clonal insulin and somatostatin secreting cell lines established from a transplantable rat islet cell tumor. Proc Natl Acad Sci USA 77: 3519–3523
Lernmark Å, Kanatsuna T, Rubenstein AH, Steiner DF (1979) Detection and possible functional influence of antibodies directed against the pancreatic islet cell surface. Adv Exp Med Bioll 15: 157–163
Idahl LÅ, Sehlin J, Täljedal IB, Thornell LE (1980) Cytotoxic activation of complement by mouse pancreatic islet cells. Diabetes 29: 636–642
Soderstrum WK, Freedman ZR, Lernmark Å (1979) Complement-dependent cytotoxic islet cell surface antibodies in insulin-dependent diabetes. Diabetes 28: 397
Dobersen MJ, Scharff JE, Ginsberg-Fellner F, Notkins AL (1980) Cytotoxic autoantibodies to beta-cells in the serum of patients with insulin-dependent diabetes mellitus. N Engl J Med 303: 1493–1498
Leddy JP, Swisher SN (1978) Acquired immune hemolytic disorders. In: Samtes M, Talmage DW, Rose B, Austen KF, Vaughan JH (eds) Immunological Diseases, Little, Brown, New York, pp 1187–1227
Lernmark Å, Bonnevie-Nielsen V, Baekkeskov S, Dyrberg T, Kanatsuna T, Scott J (1981) Islet cell antibodies. In: Martin JM, Ehrlich RM, Holland FJ (eds) Etiology and pathogenesis of insulin-dependent diabetes mellitus (Advances in Pediatric Research Series), Raven Press, New York, pp 61–71
West WH, Boozer RB, Herberman RB (1978) Low affinity E-roette formation by the human K cell. J Immunol 120: 90–95
Sensi M, Pozzilli P, Gorsuch AN, Bottazzo GF, Cudworth AG (1981) Increased killer cell activity in insulin-dependent (Type 1) diabetes mellitus. Diabetologia 20: 106–109
Kumagai S, Steinberg AD, Green I (1981) Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells. J Clin Invest 67: 604–614
Helmke K, Otten A, Willems W (1980) Islet cell antibodies in children with mumps infection. Lancet 2: 211–212
Eisenbarth GS, Oie H, Gazdar A, Chick W, Schultz JA, Scearce RM (1981) Production of monoclonal antibodies reacting with rat islet cell membrane antigens. Diabetes 30: 226–230
Baekkeskov S, Kanatsuna T, Klareskog L, Nielsen DA, Peterson PA, Rubenstein AH, Steiner DF, Lernmark Å (1981) Expression of major histocompatibility antigens on pancreatic islet cells. Proc Natl Acad Sci USA (in press)
Eisenbarth GS, Linnenbach A, Jackson R, Croce C (1981) Antibody B6: A human monoclonal anti-islet antibody. Clin Res 29:404A
Lerner RA, Sutcliffe JG, Shinnick TM (1981) Antibodies to chemically synthesized peptides predicted from DNA sequences as probes of gene expression. Cell 23: 309–310
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lernmark, Å., Baekkeskov, S. Islet cell antibodies — Theoretical and practical implications. Diabetologia 21, 431–435 (1981). https://doi.org/10.1007/BF00257781
Issue Date:
DOI: https://doi.org/10.1007/BF00257781